Search
Wednesday 24 June 2015
  • :
  • :

Pre-Market News Report on: Barnes & Noble, Inc. (NYSE:BKS), Netflix, Inc. (NASDAQ:NFLX), Plains All American Pipeline, L.P. (NYSE:PAA), Advaxis, Inc. (NASDAQ:ADXS)

On Thursday, Shares of Barnes & Noble, Inc. (NYSE:BKS), gained 1.98% to $ 24.67.

Barnes & Noble, declared the Company will report fiscal 2015 fourth quarter and year-end earnings results on Thursday, June 25th, before the market opens. The Company will host an investor conference call at 10:00 AM eastern time on Thursday, June 25th, to review the Company’s financial results and operations.

Barnes & Noble, Inc. operates as a content, commerce, and technology company in the United States. The company operates in three segments: B&N Retail, B&N College, and NOOK. It provides access to books, magazines, newspapers, and other content through its multi-channel distribution platform.

Shares of Netflix, Inc. (NASDAQ:NFLX), inclined 0.61% to $ 625.44, during its last trading session.

Netflix declared it will premiere four new animated shows, adding to its award-winning line-up of original television series for kids. The shows range from action adventure stories Kulipari: An Army of Frogs and Edgar Rice Burroughs Tarzan and Jane to preschool shows Cirque du Soleil - Luna Petunia and Puffin Rock. Each show will launch all of its episodes at the same time around the world, for all members to enjoy.

“We couldn’t be more excited to be partnering with such a diverse group of creative talent on these new Netflix series for kids,” says Erik Barmack, Netflix VP of Global Independent Content. “The flexibility of our platform allows us to continually bring the best TV shows from around the world to our members, and these titles compliment and extend what we presently offer - particularly for preschoolers and grade school adventure fans.”

Netflix, an Internet television network, engages in the Internet delivery of TV shows and movies directly on TVs, computers, and mobile devices in the United States and internationally. The company operates in three segments: Domestic Streaming, International Streaming, and Domestic DVD.

At the end of Thursday’s trade, Shares of Plains All American Pipeline, L.P. (NYSE:PAA), lost - 2.36% to $ 45.89.

Plains All American Pipeline, said it does not expect to restart before June 30 its pipeline that spilled hundreds of barrels of oil on the coast of Santa Barbara, California last month, according to Reuters.

The company said it had not set a timeline to restart the Las Flores-to-Gaviota pipeline.

The May 19 spill is estimated to be the biggest on the Santa Barbara coastline in 46 years, Reuters Reports.

Plains All American Pipeline, L.P., through with its auxiliaries, engages in the transportation, storage, terminalling, and marketing of crude oil, natural gas liquids, natural gas, and refined products in the United States and Canada. The company operates in three segments: Transportation, Facilities, and Supply and Logistics.

Finally, Advaxis, Inc. (NASDAQ:ADXS), ended its last trade with 3.37% gain, and close at $ 28.52.

Advaxis, declared the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV alone or in combination with Incyte Corporation’s investigational oral indoleamine 2,3-dioxygenase 1 inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.

In February 2015, Advaxis and Incyte reached a non-exclusive clinical trial partnership agreement to evaluate the combination of ADXS-HPV with epacadostat for the treatment of cervical cancer. The projected Phase 2 protocol is designed as a multicenter, open-label, preoperative window-study designed to evaluate the safety and efficacy of ADXS-HPV as monotherapy and in combination with epacadostat in about 30 patients with Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer. The results will be used to determine whether further clinical development of this combination is warranted.

Advaxis, a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *